Showing results (121-130 of 218) with videos related to

Sort By:
Pageof 22
Frontiers in Immunology|June 6, 2018
Phenotypic and Transcriptomic Analysis of Peripheral Blood Plasmacytoid and Conventional Dendritic Cells in Early Drug Naïve Rheumatoid ArthritisFaye A H Cooles, Amy E Anderson, Andrew Skelton, et al.
Arthritis Research & Therapy|May 18, 2006
Inhibition of macropinocytosis blocks antigen presentation of type II collagen in vitro and in vivo in HLA-DR1 transgenic miceAlexei von Delwig, Catharien M U Hilkens, Daniel M Altmann, et al.
The Journal of Clinical Endocrinology and Metabolism|July 7, 2012
Adrenal steroidogenesis after B lymphocyte depletion therapy in new-onset Addison's diseaseSimon H S Pearce, Anna L Mitchell, Stuart Bennett, et al.
Arthritis Research & Therapy|December 21, 2016
Immune reconstitution 20 years after treatment with alemtuzumab in a rheumatoid arthritis cohort: implications for lymphocyte depleting therapiesFaye A H Cooles, Amy E Anderson, Tracey Drayton, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|June 16, 2004
Neutralizing tumor necrosis factor activity leads to remission in patients with refractory noninfectious posterior uveitisConor C Murphy, Kathrin Greiner, Jarka Plskova, et al.
Annals of the Rheumatic Diseases|December 21, 2012
The role of biosimilars in the treatment of rheumatic diseasesThomas Dörner, Vibeke Strand, Gilberto Castañeda-Hernández, et al.
Annals of the Rheumatic Diseases|August 25, 2009
Dissection of the FCGR3A association with RA: increased association in men and with autoantibody positive diseaseJames I Robinson, Jennifer H Barrett, John C Taylor, et al.
Rheumatology (Oxford, England)|June 30, 2023
A proteomics study of rheumatoid arthritis patients on etanercept identifies putative biomarkers associated with clinical outcome measuresStephanie F Ling, Chuan Fu Yap, Nisha Nair, et al.
JCI Insight|January 25, 2019
Macrophage proliferation distinguishes 2 subgroups of knee osteoarthritis patientsMatthew J Wood, Adam Leckenby, Gary Reynolds, et al.
Annals of the Rheumatic Diseases|May 10, 2025
Time-independent disease state identification defines distinct trajectories determined by localised vs systemic inflammation in patients with early rheumatoid arthritisNils Steinz, Tjardo D Maarseveen, Erik B van den Akker, et al.
Pageof 22